Colgate-Palmolive Company [NYSE: CL] closed the trading session at $80.34 on 08/10/22. The day’s price range saw the stock hit a low of $79.90, while the highest price level was $80.78. The company report on August 1, 2022 that Colgate-Palmolive Company Invests in Growth of its Hill’s Pet Nutrition Business with Agreement to Buy Three Manufacturing Plants from Red Collar Pet Foods.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Colgate-Palmolive Company plans to purchase three dry pet food manufacturing plants in the U.S. from Red Collar Pet Foods for $700 million to support the global growth of its Hill’s Pet Nutrition business.
The plants – in Orangeburg, South Carolina; Clinton, Oklahoma; and Washington Court House, Ohio – will be integrated into Hill’s global supply network to produce dry pet food for Hill’s Science Diet and Prescription Diet brands. The purchase agreement includes the transfer of the approximately 350 employees involved in the dry pet food operations.
The stocks have a year to date performance of -5.86 percent and weekly performance of -1.34 percent. The stock has been moved at -0.72 percent over the last six months. The stock has performed 2.59 percent around the most recent 30 days and changed 4.79 percent over the most recent 3-months.
If compared to the average trading volume of 4.64M shares, CL reached to a volume of 3478537 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Colgate-Palmolive Company [CL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CL shares is $81.94 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CL stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Colgate-Palmolive Company shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on August 01, 2022. While these analysts kept the previous recommendation, Atlantic Equities dropped their target price from $92 to $80. The new note on the price target was released on May 03, 2022, representing the official price target for Colgate-Palmolive Company stock.
The Average True Range (ATR) for Colgate-Palmolive Company is set at 1.36, with the Price to Sales ratio for CL stock in the period of the last 12 months amounting to 3.81. The Price to Book ratio for the last quarter was 401.70, with the Price to Cash per share for the same quarter was set at 1.17. Price to Free Cash Flow for CL in the course of the last twelve months was 98.10 with Quick ratio for the last quarter at 0.70.
CL stock trade performance evaluation
Colgate-Palmolive Company [CL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.34. With this latest performance, CL shares gained by 2.59% in over the last four-week period, additionally sinking by -0.72% over the last 6 months – not to mention a rise of 2.04% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CL stock in for the last two-week period is set at 55.61, with the RSI for the last a single of trading hit 56.00, and the three-weeks RSI is set at 54.77 for Colgate-Palmolive Company [CL]. The present Moving Average for the last 50 days of trading for this stock 78.50, while it was recorded at 80.51 for the last single week of trading, and 78.83 for the last 200 days.
Colgate-Palmolive Company [CL]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Colgate-Palmolive Company [CL] shares currently have an operating margin of +22.31 and a Gross Margin at +59.08. Colgate-Palmolive Company’s Net Margin is presently recorded at +12.43.
Return on Equity for this stock inclined to 320.41, with Return on Assets sitting at 13.99.
Colgate-Palmolive Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 1.20.
Earnings per share (EPS) analysis for Colgate-Palmolive Company [CL] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Colgate-Palmolive Company go to 3.93%.
Colgate-Palmolive Company [CL]: Insider Ownership positions
There are presently around $52,737 million, or 81.90% of CL stock, in the hands of institutional investors. The top three institutional holders of CL stocks are: VANGUARD GROUP INC with ownership of 77,195,703, which is approximately 0.585% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 66,575,004 shares of the stock with an approximate value of $5.35 billion in CL stocks shares; and STATE STREET CORP, currently with $3.98 billion in CL stock with ownership of nearly 0.648% of the company’s market capitalization.
Positions in Colgate-Palmolive Company stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 696 institutional holders increased their position in Colgate-Palmolive Company [NYSE:CL] by around 38,486,891 shares. Additionally, 715 investors decreased positions by around 32,513,210 shares, while 360 investors held positions by with 585,423,680 shares. The mentioned changes placed institutional holdings at 656,423,781 shares, according to the latest SEC report filing. CL stock had 123 new institutional investments in for a total of 5,331,553 shares, while 107 institutional investors sold positions of 3,241,408 shares during the same period.